title: Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia.
abstract: OBJECTIVE
  To determine the safety and effectiveness of endoscopic injection sclerotherapy (EIS) for children with biliary atresia.
  
  
  METHODS
  Subjects were 7 patients with biliary atresia with esophagogastric varices and variceal bleeding. Intravariceal injection using 5% ethanolamine oleate was performed under fluoroscopy until varices were eradicated.
  
  
  RESULTS
  Endoscopic examination revealed that bleeding occurred in the junctional gastric varices in most of the cases. The mean number of EIS sessions required for obliteration of the varices was 2.3. In the observation period (mean: 21 months), recurrent esophagogastric varices occurred in 2 patients. One had variceal bleeding that was treated successfully by additional EIS. There were no severe complications associated with EIS.
  
  
  CONCLUSIONS
  EIS under fluoroscopy was safe and effective for variceal bleeding in children with biliary atresia.
authors.affiliation: First Department of Internal Medicine, Nagoya City University Medical School, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Horigome
authors.forename: T
authors.initials: T
authors.lastname: Nomura
authors.forename: K
authors.initials: K
authors.lastname: Saso
authors.forename: T
authors.initials: T
authors.lastname: Hashimoto
authors.forename: T
authors.initials: T
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Joh
authors.forename: H
authors.initials: H
authors.lastname: Ohara
authors.forename: S
authors.initials: S
authors.lastname: Akita
authors.forename: S
authors.initials: S
authors.lastname: Sobue
authors.forename: Y
authors.initials: Y
authors.lastname: Mizuno
authors.forename: Y
authors.initials: Y
authors.lastname: Kato
authors.forename: H
authors.initials: H
authors.lastname: Ohmi
authors.forename: M
authors.initials: M
authors.lastname: Itoh
mesh_terms: D000293:Adolescent; D001656:Biliary Atresia / Q000150:complications* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000628:therapy*; D004945:Esophagoscopy; D005260:Female; D005336:Fiber Optic Technology; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D009829:Oleic Acids / Q000008:administration & dosage*; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000627:therapeutic use*; D015911:Sclerotherapy / Q000379:methods*
chemical_list: D009829:Oleic Acids; D012597:Sclerosing Solutions; C033343:ethanolamine oleate